Bladder cancer.
Dyrskjøt L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D.
Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9.
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA.
Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12.
Bladder Cancer: A Review.
Lenis AT, Lec PM, Chamie K, Mshs MD.
JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598.
[Transurethral resection of bladder tumors (TURBT)].
Oswald D, Pallauf M, Herrmann TRW, Netsch C, Becker B, Lehrich K, Miernik A, Schöb DS, Sievert KD, Gross AJ, Westphal J, Lusuardi L, Deininger S.
Urologe A. 2022 Jan;61(1):71-82. doi: 10.1007/s00120-021-01741-z. Epub 2022 Jan 4.
Radical Transurethral Resection of Bladder Tumor in Seemingly Organ-confined Muscle-invasive Bladder Cancer: Con.
Maas M, Black PC.
Eur Urol Focus. 2023 Mar;9(2):223-224. doi: 10.1016/j.euf.2022.09.013. Epub 2022 Oct 8.
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer.
Lidagoster S, Ben-David R, De Leon B, Sfakianos JP.
Curr Oncol. 2024 Feb 16;31(2):1063-1078. doi: 10.3390/curroncol31020079.
Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.
Zheng Y, Ye Y, Chen J, Wei Z, Liu Z, Yu K, Zhang X.
Int J Surg. 2022 Jul;103:106693. doi: 10.1016/j.ijsu.2022.106693. Epub 2022 Jun 9.
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
Vulsteke C, Adra N, Danchaivijitr P, Sabadash M, Rodriguez-Vida A, Zhang Z, Atduev V, Göger YE, Rausch S, Kang SH, Loriot Y, Bedke J, Galsky MD, O'Donnell PH, von Amsberg G, Alimohamed N, Sulimka G, Gupta S, Paramonov V, Nakane K, Mihm M, Meng C, Huang CD, Ramamurthy C, Homet Moreno B, Ullén A; KEYNOTE-905/EV-303 Investigators.
N Engl J Med. 2026 Apr 2;394(13):1257-1269. doi: 10.1056/NEJMoa2511674. Epub 2026 Feb 18.
Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
Roumiguié M, Wong A, Belanger E, Wang G, Black PC.
Urol Oncol. 2023 May;41(5):254.e9-254.e15. doi: 10.1016/j.urolonc.2022.10.033. Epub 2022 Dec 22.
Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy).
Castagnetti M, Herbst KW, Esposito C.
Curr Opin Urol. 2019 Sep;29(5):487-492. doi: 10.1097/MOU.0000000000000651.
